about
The expanding regulatory universe of p53 in gastrointestinal cancerNoncoding RNAs and pancreatic cancermiR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2.Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer.The potential of microRNAs in personalized medicine against cancers.Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biologyRole of microRNAs on therapy resistance in Non-Hodgkin's lymphoma.miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.MicroRNA-299-3p promotes the sensibility of lung cancer to doxorubicin through directly targeting ABCE1.Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin.A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125bImpaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients.miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression.cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation.Understanding microRNA-mediated gene regulatory networks through mathematical modelling.MicroRNA-552 enhances metastatic capacity of colorectal cancer cells by targeting a disintegrin and metalloprotease 28.MicroRNAs in personalized cancer therapy.Noncoding RNA response to xenobiotic exposure: an indicator of toxicity and carcinogenicity.miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.The Role of MicroRNAs in the Chemoresistance of Breast Cancer.MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathway.miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance.Selective activation of miRNAs of the primate-specific chromosome 19 miRNA cluster (C19MC) in cancer and stem cells and possible contribution to regulation of apoptosis.Mir-221/222 are promising targets for innovative anticancer therapy.An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).MiR-33b-5p sensitizes gastric cancer cells to chemotherapy drugs via inhibiting HMGA2 expression.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.miRNAs: mediators of ErbB family targeted therapy resistance.Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma.Suppression of Dicer increases sensitivity to gefitinib in human lung cancer cells.Machine Learning Approaches Toward Building Predictive Models for Small Molecule Modulators of miRNA and Its Utility in Virtual Screening of Molecular Databases.MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM.MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance.
P2860
Q26742058-6127309E-67FA-4E97-AD13-6DB564046D5DQ26774630-92DFEF8C-2863-4331-8E82-6E44549B7CA8Q28606716-A9DBE539-EDE3-4FA7-A0CE-E7D15D42294FQ33726141-CBAD489A-CE20-4FD3-A337-2CD7A689A70BQ33850064-11C51C2F-47E4-4B04-9F15-F521A64976C2Q34177065-09531B01-7BF0-4C4D-994C-4ABBD9A8B545Q34177547-9362C15C-070C-41A8-9C69-778C1626B45DQ34436424-1082B5C8-761D-4F04-AAC9-3076D2D912EDQ34769735-96BFB2F5-0B6A-460D-8F77-0D18233A0231Q35291824-411A13E0-858E-456D-99B5-A9646FBEA385Q36139783-D1DC159D-32CB-4B4F-8B5F-164E0814C7C2Q36261264-54F78103-6C61-4B14-848B-EFE57EA065F0Q36338901-D602E0EF-2404-4B24-88CC-9CB7002D2C4AQ36499755-D2D4F248-543D-43B7-9BD1-05799218204DQ36642951-DF72DAF6-F1EF-4485-B691-FE59E85A3EE3Q36782461-1C41F91B-36F7-4DCC-B511-182C4A348213Q37327471-3675C711-A74B-429E-B017-DFEC2215CF0FQ37376531-F4622121-CA8A-422C-AA0C-0D100729016CQ37520983-9C359B6C-88FD-40BF-B1EE-92025A8CF8D1Q37623783-BF86FBFB-518E-4A9F-8062-20B03074FCB0Q37688510-6E27EB7E-EC62-424A-B4BB-1EC856B07E5EQ38196460-1B59FFE9-9B24-4522-AE40-556C0DAF622AQ38244618-6A7E528E-EDCE-47BE-AF6C-5FE6E4431F1FQ38366731-5667C5E5-44E1-48D9-B162-54A6871CCCEDQ38546133-BE075CA7-3FB7-49B7-8BD3-B40670916568Q38574546-E29AB246-B308-445F-A1CF-181B3A40154CQ38604500-B2CA9F7B-7F71-475D-81CF-D5E2F5AD31E8Q38633144-2410EEBF-2944-44D7-A250-0C18521FB49EQ38713237-3DF832D8-F180-46F4-A7EF-F93D1ABBF70CQ38767024-AF09D31A-2056-4596-AE06-15719E972C8DQ38771776-C1E8BDE7-6015-4495-89F4-E2E67C7A514FQ38823432-DE107273-0545-4F15-9F89-59E3C34325B5Q38869922-8740FAE5-EE7C-4664-8184-EA80EF7BF3DCQ38881549-B7FF4797-4A54-480A-A481-5E39EA022521Q38940586-45E1418F-BFA8-43E4-8921-093F2E9D37C4Q38975570-8CCCF2C7-3A5B-4D5B-A9AB-B9D4CBCBDDD2Q39005277-988588DF-311B-4959-9717-9D7A689A938DQ39125361-880A2083-29D4-43EB-9A73-6557D1707578Q39990148-5A495D96-BAAA-4A5A-B8D3-9BF7AA97D3C6Q41126784-051B9E44-C4FE-4CED-B63A-F487E8F0B2D1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs as therapeutic targets in chemoresistance.
@en
MicroRNAs as therapeutic targets in chemoresistance.
@nl
type
label
MicroRNAs as therapeutic targets in chemoresistance.
@en
MicroRNAs as therapeutic targets in chemoresistance.
@nl
prefLabel
MicroRNAs as therapeutic targets in chemoresistance.
@en
MicroRNAs as therapeutic targets in chemoresistance.
@nl
P2860
P1476
MicroRNAs as therapeutic targets in chemoresistance.
@en
P2093
Michela Garofalo
P2860
P356
10.1016/J.DRUP.2013.05.001
P577
2013-06-10T00:00:00Z